Search Page

1

Cite

Share

Seizing Control of KCC2: A New Therapeutic Target for Epilepsy.

Moore YE, Kelley MR, Brandon NJ, Deeb TZ, Moss SJ. Moore YE, et al. Trends Neurosci. 2017 Sep;40(9):555-571. doi: 10.1016/j.tins.2017.06.008. Epub 2017 Aug 10. Trends Neurosci. 2017. PMID: 28803659 Review.

Cite

Share

2

Cite

Share

Recovery from chronic fatigue syndrome: a systematic review-heterogeneity of definition limits study comparison.

Moore Y, Serafimova T, Anderson N, King H, Richards A, Brigden A, Sinai P, Higgins J, Ascough C, Clery P, Crawley EM. Moore Y, et al. Arch Dis Child. 2021 Nov;106(11):1087-1094. doi: 10.1136/archdischild-2020-320196. Epub 2021 Apr 12. Arch Dis Child. 2021. PMID: 33846138 Free PMC article.

Cite

Share

3

Cite

Share

First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study.

Wainberg ZA, Bekaii-Saab T, Boland PM, Dayyani F, Macarulla T, Mody K, Belanger B, Maxwell F, Moore Y, Thiagalingam A, Wang T, Zhang B, Dean A. Wainberg ZA, et al. Among authors: moore y. Eur J Cancer. 2021 Jul;151:14-24. doi: 10.1016/j.ejca.2021.03.028. Epub 2021 May 4. Eur J Cancer. 2021. PMID: 33957442 Free article. Clinical Trial.

Cite

Share

4

Cite

Share

Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase.

Sachdev JC, Munster P, Northfelt DW, Han HS, Ma C, Maxwell F, Wang T, Belanger B, Zhang B, Moore Y, Thiagalingam A, Anders C. Sachdev JC, et al. Among authors: moore y. Breast Cancer Res Treat. 2021 Feb;185(3):759-771. doi: 10.1007/s10549-020-05995-7. Epub 2020 Nov 17. Breast Cancer Res Treat. 2021. PMID: 33201358 Free PMC article. Clinical Trial.

Cite

Share

5

Cite

Share

Growth/differentiation factor-5: a candidate therapeutic agent for periodontal regeneration? A review of pre-clinical data.

Moore YR, Dickinson DP, Wikesjö UM. Moore YR, et al. J Clin Periodontol. 2010 Mar;37(3):288-98. doi: 10.1111/j.1600-051X.2009.01527.x. Epub 2010 Jan 19. J Clin Periodontol. 2010. PMID: 20088982 Review.

Cite

Share

6

Cite

Share

N-Ethylmaleimide increases KCC2 cotransporter activity by modulating transporter phosphorylation.

Conway LC, Cardarelli RA, Moore YE, Jones K, McWilliams LJ, Baker DJ, Burnham MP, Bürli RW, Wang Q, Brandon NJ, Moss SJ, Deeb TZ. Conway LC, et al. Among authors: moore ye. J Biol Chem. 2017 Dec 29;292(52):21253-21263. doi: 10.1074/jbc.M117.817841. Epub 2017 Nov 1. J Biol Chem. 2017. PMID: 29092909 Free PMC article.

Cite

Share

7

Cite

Share

Cannabidiol reduced frequency of convulsive seizures in drug resistant Dravet syndrome.

Moore Y, Robinson R. Moore Y, et al. Arch Dis Child Educ Pract Ed. 2018 Oct;103(5):278-279. doi: 10.1136/archdischild-2017-313700. Epub 2017 Sep 22. Arch Dis Child Educ Pract Ed. 2018. PMID: 28939549 No abstract available.

Cite

Share

8

Cite

Share

Influenza vaccine administration in a paediatric intensive care unit.

Elia S, Moore Y, Duke T, Crawford NW, Tosif S. Elia S, et al. Among authors: moore y. J Paediatr Child Health. 2022 Jun 24. doi: 10.1111/jpc.16083. Online ahead of print. J Paediatr Child Health. 2022. PMID: 35748619

Cite

Share

9

Cite

Share

Developmental Regulation of KCC2 Phosphorylation Has Long-Term Impacts on Cognitive Function.

Moore YE, Conway LC, Wobst HJ, Brandon NJ, Deeb TZ, Moss SJ. Moore YE, et al. Front Mol Neurosci. 2019 Jul 23;12:173. doi: 10.3389/fnmol.2019.00173. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31396048 Free PMC article.

Cite

Share

10

Cite

Share

Gastrointestinal comorbidities associated with atrial fibrillation.

Laliberté F, Moore Y, Dea K, LaMori JC, Mody SH, Jones JL, Arledge MD, Damaraju CV, Schein JR, Lefebvre P. Laliberté F, et al. Among authors: moore y. Springerplus. 2014 Oct 15;3:603. doi: 10.1186/2193-1801-3-603. eCollection 2014. Springerplus. 2014. PMID: 25392776 Free PMC article.

Cite

Share